A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan

被引:0
|
作者
Takumi Hirata
Daisuke Sugiyama
Shin-ya Nagasawa
Yoshitaka Murakami
Shigeyuki Saitoh
Akira Okayama
Hiroyasu Iso
Fujiko Irie
Toshimi Sairenchi
Yoshihiro Miyamoto
Michiko Yamada
Shizukiyo Ishikawa
Katsuyuki Miura
Hirotsugu Ueshima
Tomonori Okamura
机构
[1] Keio University School of Medicine,Center for Supercentenarian Medical Research
[2] Keio University School of Medicine,Department of Preventive Medicine and Public Health
[3] Kanazawa Medical University,Department of Epidemiology and Public Health
[4] Toho University,Division of Medical Statistics, Department of Social Medicine, Faculty of Medicine
[5] Sapporo Medical University School of Health Sciences,Department of Nursing
[6] Research Institute of Strategy for Prevention,Department of Social and Environmental Medicine
[7] Osaka University Graduate School of Medicine,Department of Health and Welfare
[8] Ibaraki Prefectural Office,Department of Public Health
[9] Dokkyo Medical University School of Medicine,Department of Preventive Medicine and Epidemiologic Informatics
[10] National Cerebral and Cardiovascular Center,Department of Clinical Studies
[11] Radiation Effects Research Foundation,Center for Community Medicine
[12] Jichi Medical University,Department of Public Health
[13] Shiga University of Medical Science,Center for Epidemiologic Research in Asia
[14] Shiga University of Medical Science,undefined
来源
European Journal of Epidemiology | 2017年 / 32卷
关键词
Cardiovascular diseases; Epidemiology; High-density lipoprotein cholesterol; Mortality;
D O I
暂无
中图分类号
学科分类号
摘要
Low levels of serum high-density lipoprotein cholesterol (HDL-C) have been shown to be associated with increased risk of coronary heart disease (CHD). However, because this is usually observed in the context of other lipid abnormalities, it is not known whether isolated low serum HDL-C levels are an independent risk factor for CHD. We performed a large pooled analysis in Japan using data from nine cohorts with 41,206 participants aged 40–89 years who were free of cardiovascular disease at baseline. We divided participants into three groups: isolated low HDL-C, non-isolated low HDL-C, and normal HDL-C. Cohort-stratified Cox proportional hazards models were used to estimate multivariate-adjusted hazard ratios (HRs) for death due to CHD, ischemic stroke, and intracranial cerebral hemorrhage; during a 12.9-year follow-up, we observed 355, 286, and 138 deaths, respectively, in these groups. Non-isolated low HDL-C was significantly associated with increased risk of CHD compared with normal HDL-C (HR 1.37, 95 % confidence interval (CI) 1.04–1.80); however, isolated low HDL-C was not. Although isolated low HDL-C was significantly associated with decreased risk of CHD (HR 0.51, 95 % CI 0.29–0.89) in women, it was significantly associated with increased risk of intracranial cerebral hemorrhage in all participants (HR 1.62, 95 % CI 1.04–2.53) and in men (HR 2.00, 95 % CI 1.04–3.83). In conclusion, isolated low HDL-C levels are not associated with increased risk of CHD in Japan. CHD risk may, therefore, be more strongly affected by serum total cholesterol levels in this population.
引用
收藏
页码:547 / 557
页数:10
相关论文
共 50 条
  • [31] Residual Risk and High-Density Lipoprotein Cholesterol Levels: Is There a Relationship?
    Shah, Prediman K.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2011, 12 (02) : E55 - E59
  • [32] Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants
    Hye Jun Kim
    Seogsong Jeong
    Yun Hwan Oh
    Sun Jae Park
    Yoosun Cho
    Sang Min Park
    Cardiovascular Diabetology, 22
  • [33] Increased plasma monocyte chemoattractant protein-1 levels in patients with isolated low high-density lipoprotein cholesterol
    Karabacak, Mustafa
    Kahraman, Fatih
    Sert, Mehmet
    Celik, Erdal
    Adali, Mehmet Koray
    Varol, Ercan
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2015, 75 (04) : 327 - 332
  • [34] Association between hematological parameters and high-density lipoprotein cholesterol
    Moriarty, PM
    Gibson, CA
    CURRENT OPINION IN CARDIOLOGY, 2005, 20 (04) : 318 - 323
  • [35] Association of High-Density Lipoprotein Cholesterol With GFR Decline in a General Nondiabetic Population
    Melsom, Toralf
    Norvik, Jon Viljar
    Enoksen, Inger Therese
    Stefansson, Vidar
    Rismo, Renathe
    Jenssen, Trond
    Solbu, Marit D.
    Eriksen, Bjorn O.
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (08): : 2084 - 2094
  • [36] Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis
    Zampino, Rosa
    Patauner, Fabian
    Karruli, Arta
    Iossa, Domenico
    Ursi, Maria Paola
    Bertolino, Lorenzo
    Peluso, Anna Maria
    D'Amico, Fabiana
    Cavezza, Giusi
    Durante-Mangoni, Emanuele
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)
  • [37] The association between diabetes coexisting with low levels of high-density lipoprotein cholesterol and peritoneal dialysis-related peritonitis
    Zhang, Rui
    Zhang, Xing
    Tang, Xingming
    Tang, Liwen
    Shang, Sijia
    Wang, Xiaoyang
    Wen, Yueqiang
    Feng, Xiaoran
    Zhou, Qian
    Su, Ning
    Huang, Yajuan
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01)
  • [38] The association between diabetes coexisting with low levels of high-density lipoprotein cholesterol and peritoneal dialysis-related peritonitis
    Rui Zhang
    Xing Zhang
    Xingming Tang
    Liwen Tang
    Sijia Shang
    Xiaoyang Wang
    Yueqiang Wen
    Xiaoran Feng
    Qian Zhou
    Ning Su
    Yajuan Huang
    Diabetology & Metabolic Syndrome, 14
  • [39] Association of ratios of monocyte/high-density lipoprotein cholesterol and neutrophil/high-density lipoprotein cholesterol with atherosclerotic plaque type on coronary computed tomography
    Okan, Taha
    Topaloglu, Caner
    CARDIOVASCULAR JOURNAL OF AFRICA, 2024,
  • [40] Treating low high-density lipoprotein cholesterol: what is the evidence?
    Hage, Mirella P.
    Azar, Sami T.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2014, 5 (01) : 10 - 17